A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
Hewitt HB, Blake ER, Walder AS. · 1976
Read A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. by Hewitt HB, Blake ER, Walder AS. (1976) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2024987.txt.
Introduction
Hewitt, Blake and Walder challenged in 1976 the popular idea that the body actively defends itself against cancer. Their evidence came from 27 mouse tumours that arose spontaneously, not from chemicals or viruses. Such tumours were transplanted between genetically matched mice. The authors argue these are the only fair models of human cancer. Chemically induced tumours, they say, create artificial immunity.
Across roughly 20,000 maintenance transplants, not one failed or shrank away. Almost 10,000 tumours from small cell doses were watched, and none regressed on their own. Prior injection of irradiated tumour cells actually made recipients more receptive, not less. Lymphocytes from sensitised mice gave no protection either. The team found no trace of tumour immunogenicity, meaning no immune rejection of these cancers.
Catalog record
| CREATOR | Hewitt HB, Blake ER, Walder AS. |
|---|---|
| YEAR | 1976 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 80 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. By H. B. Hewitt, E. R. Blake, A. S. Walder Published in: British Journal of Cancer DOI: 10.1038/bjc.1976.37 ABSTRACT Extensive experience with isotransplants of 27 different tumours (leukaemias, sarcomata, carcinomata), all of strictly spontaneous origin in laboratory bred mice of low cancer strains CBA/Ht and WHT/Ht, has revealed no evidence of tumour immunogenicity. Of approximately 20,000 maintenance transplants, none failed and none regressed; of almost 10,000 carefully observed tumours arising from small or minimal inocula of tumour cells, none spontaneously regressed. The number of injected viable tumour cells required to give a 50% probability of successful transplantation (the TD50) ranged from approximately 1 cell to greater than 10,000 cells among the 27 tumours; high TD50 values, which were dramatically reduced by various procedures having no immunological significance, did not signify active "resistance" of the hosts. In the case of all of 7 randomly selected tumours, prior "immunization" of recipients with homologous lethally irradiated cells increased their tumour receptivity. Several experiments using various tumours failed to give evidence that immunity could be non-specifically induced or that a massive preponderance of lymphocytes from specifically sensitized mice could inhibit tumour transplantation or growth in vivo; no trace of "resistance" to tumour was adopted by isogeneic recipients of lymphocytes from regional nodes of tumour bearers. A limited review of the recent literature on tumour immunity shows that practically all the animal data presented in support of a general theory of tumour immunogenicity or to provide a basis for active clinical immunotherapy have been obtained from transplanted tumour systems which entail artefactual immunity associated with viral or chemical induction of the tumours or their allogeneic transplantation. It is suggested that isotransplants of spontaneously arising tumours are the only appropriate models of human cancer and that any genuine rapport between the animal laboratory and the clinic requires their exclusive use. Br. J. Cancer (1976) 33, 241 A CRITIQUE OF THE EVIDENCE FOR ACTIVE HOST DEFENCE AGAINST CANCER, BASED ON PERSONAL STUDIES OF 27 MURINE TUMOURS OF SPONTANEOUS ORIGIN H. B. HEWITT, E. R. BLAKE AND A. S. WALDER From the C. R. C. Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, HA6 2RN, England Received 3 October 1975 Accepted 29 November 1975 Summary.-Extensive experience with isotransplants of 27 different tumours (leukaemias, sarcomata, carcinomata), all of strictly spontaneous origin in laboratory bred mice of low cancer strains CBA/Ht and WHT/Ht, has revealed no evidence of tumour immunogenicity. Of approximately 20,000 maintenance transplants, none failed and none regressed; of almost 10,000 carefully observed tumours arising from small or minimal inocula of tumour cells, none spontaneously regressed. The number of injected viable tumour cells required to give a 50% probability of successful transplantation (the TD50) ranged from 1 cell to > 10,000 cells among the 27 tumours; high TD50 values, which were dramatically reduced by various procedures having no immunological significance, did not signify active" resistance " of the hosts. In the case of all of 7 randomly selected tumours, prior "immuniza- tion " of recipients with homologous lethally irradiated cells increased their tumour receptivity. Several experiments using various tumours failed to give evidence that immunity could be non-specifically induced or that a massive preponderance of lymphocytes from specifically sensitized mice could inhibit tumour transplantation or growth in vivo; no trace of " resistance " to tumour was adopted by isogeneic recipients of lymphocytes from regional nodes of tumour bearers. A limited review of the recent literature on tumour immunity shows that practically all the animal data presented in support of a general theory of tumour immunogenicity or to provide a basis for active clinical immunotherapy have been obtained from transplanted tumour systems which entail artefactual immunity associated with viral or chemical induction of the tumours or their allogeneic transplantation. It is suggested that isotransplants of spontaneously arising tumours are the only appropriate models of human cancer and that any genuine rapport between the animal laboratory and the clinic requires their exclusive use. WE REPORT here a considerable volume of data concerning the transplantation characteristics of a large number and variety of murine tumours having the distinction that they were all of strictly spontaneous origin in low cancer strain mice. The data, collected over many years of experimentation, have some additional claim to uniqueness from the exceptionally uniform conditions under which the information was obtained: the breeding colonies of inbred mice have been managed in every detail by one of us 16 (A.S.W.); all other technical procedures have been carried out personally by the authors without additional assistance; to validate comparison of data between different tumours and from time to time over long periods of any one tumour's history, the routine technical procedures have not been varied in any significant particular; and, finally, a detailed record has been kept of the fate of every mouse used in every experiment, permitting the retrospective analysis of our experience which we are to report. H. B. HEWITT, E. R. BLAKE AND A. S. WALDER A feature of our experiments, required by the studies of tumour radiobiology and of metastasis to which they contributed, was that all transplantations (except maintenance and preparatory passages) were made quantitatively using counted tumour cell suspensions and mostly em- ploying several uniformly injected sites per mouse. Since the success of such grafts is determined by some function relating the size of the inoculum and the receptivity of the injectee, it is clear that our collected data are in some way expres- sive of the host/tumour relationship; they deserve serious consideration in the con- text of tumour immunology. Whilst that topic has certainly not instigated our studies, the interpretation of our experi- mental results has required continual alertness to the possible complicity of an immunological response of the hosts. Our vigilance was stimulated by the prevalent theory that neoantigens necessarily emerge at malignant transformation, implying that potential tumour immunogenicity is intrinsic to tumour biology. From an early satisfaction that we had been fortunate to escape complications from this ingredient, we have progressed to our present con- viction that our experience conflicts abso- lutely with the broad assertion that tumour immunogenicity is a common and detectable feature of spontaneous cancer. We believe that this conflict arises out of our deliberate and exclusive use of tumours of spontaneous origin isogeneic- ally transplanted within our own inbred mouse colonies. Our purpose here is to present features of our broad experience which appear significant in the context of tumour immunology, as presented by the reports of host response against experimental tumours and in respect of its relevance to human cancer. Consideration of our experience has compelled us to examine more closely the evidential basis of the concept of tumour immunogenicity as derived from clinical observation and, further, to examine critically the status of the profusion of animal tumour data that now underpins the fragile structure of clinical impression. Our object will be to enquire whether the apparent singularity of our findings can be ascribed to the category of tumour we have exclusively studied. We shall initiate this enquiry here and pursue it more pointedly in the Discussion of our findings. A concept